T2 Biosystems Inc expected to post a loss of 4 cents a share - Earnings Preview

T2 Biosystems

10/10/2023 21:02

* T2 Biosystems Inc  TTOO.OQ   TTOO.O  is expected to show a
fall
in quarterly revenue when it reports  results 
    * The Lexington Massachusetts-based  company is expected to
report
 a 29.3% decrease in revenue to $2.6 million from $3.68 million
a year ago, according to the estimate from one analyst, based on
Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for T2 Biosystems Inc
is for
a loss of 4 cents per share. 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts had risen by
about 41.2%
in the last three months. ​
    * Wall Street's median 12-month price target for T2
Biosystems Inc
is $0.15​, below​ its last closing price of $0.28. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2023  -0.25       -0.27      -0.08     Beat    70
 Mar. 31 2023  -1.20       -1.20      -1.32     Missed  -9.7
 Dec. 31 2022  -1.67       -1.70      -1.41     Beat    17.3​
 Sep. 30 2022  -2.05       -2.04      -2.95     Missed  -44.4
 ​​Jun.        -4.50       -4.50      -5.00     Missed  -11.1
 30 2022                                                
 Mar. 31 2022  -3.72       -3.75      -5.00     Missed  -33.3​
 Dec. 31 2021  -4.50       -4.50      -3.50     Beat    22.2
 Sep. 30 2021  -4.23       -4.25      -4.00     Beat    5.9
 This summary was machine generated October 10 at 20:02 GMT.  All
figures in US dollars  unless otherwise stated